User profiles for Mobina Khericha

Mobina Khericha, PhD

UCLA
Verified email at ucla.edu
Cited by 670

Sex difference in pathology of the ageing gut mediates the greater response of female lifespan to dietary restriction

JC Regan, M Khericha, AJ Dobson, E Bolukbasi… - elife, 2016 - elifesciences.org
10.7554/eLife.10956.001 Women live on average longer than men but have greater levels
of late-life morbidity. We have uncovered a substantial sex difference in the pathology of the …

[PDF][PDF] Short-term, intermittent fasting induces long-lasting gut health and TOR-independent lifespan extension

JH Catterson, M Khericha, MC Dyson, AJ Vincent… - Current Biology, 2018 - cell.com
Intermittent fasting (IF) can improve function and health during aging in laboratory model
organisms, but the mechanisms at work await elucidation. We subjected fruit flies (Drosophila …

[HTML][HTML] Direct Keap1-Nrf2 disruption as a potential therapeutic target for Alzheimer's disease

…, I Snoeren, HM Cocheme, J Adcott, M Khericha… - PLoS …, 2017 - journals.plos.org
Nrf2, a transcriptional activator of cell protection genes, is an attractive therapeutic target for
the prevention of neurodegenerative diseases, including Alzheimer’s disease (AD). Current …

[HTML][HTML] CAR-T cell manufacturing: Major process parameters and next-generation strategies

M Ayala Ceja, M Khericha, CM Harris… - Journal of Experimental …, 2024 - rupress.org
Chimeric antigen receptor (CAR)-T cell therapies have demonstrated strong curative potential
and become a critical component in the array of B-cell malignancy treatments. Successful …

CD19/CD20 bispecific chimeric antigen receptor (CAR) in naive/memory T cells for the treatment of relapsed or refractory non-Hodgkin lymphoma

…, J Trent, JM Chen, M Roshandell, C Harris, M Khericha… - Cancer discovery, 2023 - AACR
Autologous CD19/CD20 bispecific CAR-T cell therapy generated from T N/MEM cells for
patients with NHL is safe (no neurotoxicity, maximum grade 1 cytokine release syndrome) and …

[HTML][HTML] Lithium suppresses Aβ pathology by inhibiting translation in an adult Drosophila model of Alzheimer's disease

…, I Rogers, L Li, P Martinez, M Khericha… - Frontiers in aging …, 2014 - frontiersin.org
The greatest risk factor for Alzheimer's disease (AD) is age, and changes in the ageing
nervous system are likely contributors to AD pathology. Amyloid beta (Aβ) accumulation, which …

[PDF][PDF] Intestinal fork head regulates nutrient absorption and promotes longevity

E Bolukbasi, M Khericha, JC Regan, DK Ivanov… - Cell reports, 2017 - cell.com
Reduced activity of nutrient-sensing signaling networks can extend organismal lifespan, yet
the underlying biology remains unclear. We show that the anti-aging effects of rapamycin …

[HTML][HTML] pGluAβ increases accumulation of Aβ in vivo and exacerbates its toxicity

O Sofola-Adesakin, M Khericha, I Snoeren… - Acta neuropathologica …, 2016 - Springer
Several species of β-amyloid peptides (Aβ) exist as a result of differential cleavage from
amyloid precursor protein (APP) to yield various C-terminal Aβ peptides. Several N-terminal …

Trametinib ameliorates aging-associated gut pathology in Drosophila females by reducing Pol III activity in intestinal stem cells

…, YX Lu, E Bolukbasi, M Khericha… - Proceedings of the …, 2024 - National Acad Sciences
Pharmacological therapies are promising interventions to slow down aging and reduce
multimorbidity in the elderly. Studies in animal models are the first step toward translation of …

Rational Protein Design Yields a CD20 CAR with Superior Antitumor Efficacy Compared with CD19 CAR

X Chen, LC Chen, M Khericha, X Meng… - Cancer immunology …, 2023 - AACR
Mobina KherichaMobina Khericha … Chen, Mobina Khericha, Xiangzhi Meng, Emma
Salvestrini, Amanda Shafer, Neha Iyer, Anya S. Alag, Yunfeng Ding, Demetri M. Nicolaou, Yvonne Y. …